according to today's downgrades by Canaccord and UBS. Stock might tank 20% and more today given that everybody already took for granted that the new IPhone would indeed have a sapphire display. Even worse - how will Apple differentiate their new phone from the competition without premium design and innovation
given results and outlook the company will be able to do another secondary at much better terms than just a few weeks ago - good move to wait until the stock price finally went in the right direction for them. Would wait for the secondary to get some exposure.
on the other hand even at next quarter's revenue level the company won't be profitable and cash burn will stay high
nobody cares about the eps number here - listen to the conference call to get an impression what really matters to analysts. All important metrics came in in great shape so clearly I would expect the shares to trade up substantially tomorrow.
They were spot on GOMO and they put out a pretty detailed report on VNET which has months of field work in it so they clearly have some valid points here.
yes - they are right - PIP is prevented from any kind of enforcement action under chapter 11 - same thing was done by the asbestos companies 20 years ago.
most shareholders remained in the stock because of the dividend - with this incentive mostly gone investors are moving on. I can't blame them. The stock is dead money at the very best but I wouldn't be surprised at all if this will undergo chapter 11 proceedings with two or three years from here.
unexpected reviews do NOT take place without serious cause for concern. The press release already reveals that there have been "serious adverse events related to allergic reactions" so it is quite clear that the drug is a failure. The trial will be stopped and the drug be abandoned.
"Arthur "Art" Krieg, M.D., has been named senior vice president and chief scientific officer. In this role, Dr. Krieg will lead the company’s drug discovery and early-stage research activities."
just take a look at the PE the shares are trading and you will soon realize that this is not a value investment as the shares look excessively overpriced at current levels. The company has been picked up as a high margin, high growth cloud services play and therefore analysts are looking for continued customer additions, international growth, increased arpu, low churn and so on. Eps can be lumpy quarter over quarter as marketing campaigns or sales force hires could put temporary pressure on the bottom line. So do yourself a big favor and read the cc transscript tomorrow and you will know what this is really all about.
"to more normal levels" - gross margin improvement won't hold going forward as some r&d expenses were simply pushed out. Would short the shares in after hours as management sounds cautious heading into 2015
nonsense - company didn't deliver on its own shipment and especially margin guidance. All metrics have worsened compared to Q1 and guidance is for continued gross margin pressure going forward. There's no way the company will turn a profit in Q3 or even Q4. Would like to hear how they plan to address the upcoming convert maturity.
VERY disappointing results and outlook - much worse than other companies in the sector when looking at the gross margins
Management explained this in detail on the conference call - just listen to the replay of today's call - while financing clearly is not a problem the deal looks ill-fated as it was seemingly put together head over heels in light of the recent IGT takeout. Analysts on the call especially doubted the forecasted cost synergies and asked about potential FTC issues. Overall the deal recption was pretty lukewarm. Even worse management outright rejected to talk about the agreed breakup fee on the call and hinted to an upcoming SEC filing instead which won't be filed immediately.
Bally shareholders should take their money and RUN fast as there's a high probability of the deal to fall through as already evidenced by today's trading action. Would outright short SGMS as they will be pressured by a seemingly very high breakup fee.
they should have filed for a bigger secondary - this will buy them just another year at best
Cash is down another $18 mln for the quarter and will continue to decline at this pace for at least two more quarters. Remarks about demand outstripping capacity is mainly a function of ramp up difficulties and very small current capacity. Further substantial investment is required to double output before year end.
Analysts on the call clearly NOT buying the rosy picture yet. Many questions around the huge guide down for next quarter, the sale of the ultra-high-margin Japan business and another possible revenue step down for the December quarter.
Would steer clear of the shares here and revisit the company after Q4 results.
obviously PLUG shareholders are even too stupid to check the SEC site for the filing
another great call
The latest earnings were bad - really bad. The company continues to struggle with almost everything and there were no real improvements visible from an already very weak Q1. Gross margins dropped 4.1% qoq which is almost too bad to be true. Given the ongoing dismal performance of the company some investors obviously feared bankruptcy to become an short term option and sold out regardless of the price point.
And while bankruptcy might very well be in the cards at some time going forward the company isn't there yet. Delia has a few million dollars of cash on hand coupled with more than $8 mln in restricted cash (supporting letters of credit). And they still have $16 mln available under the Salus Capital credit line.
They also carry almost $30 million dollars of inventories on the balance sheet while bank debt and accounts payable stand at a combined $20 mln.
At current prices the market cap of the company is just around $20 mln which clearly is a "left for dead" valuation especially when considering that the company has NO current or even medium term liquidity issues given the balance sheet and the huge credit line availability. Furthermore I would doubt that the activist investors involved with the company would give up on Delia even after some more poor quarters.
Even more noticeable management guided for some improvement in Q3 on the call - and given the bombed out share price ANY kind of improvement in revenues or gross margins might trigger a huge rally in the shares.
Even with another ugly quarter the company is not at risk of immediate bankruptcy so I guess the shares shouldn't drop much further anyway.
Would expect the shares to recover most of their earnings related losses going into the Q3 earnings release in December.
as expected the latest acquisition seems to once again fire back on management